|
?:authorAffiliation
|
-
[\'Bond Life Sciences Center, University of Missouri, Columbia, MO, 65211, USA.\', \'Department of Medicine, University of Missouri, Columbia, MO, 65211, USA.\', \'Department of Immunology and Nanomedicine, Florida International University, Miami, FL, USA.\', \'Department of Biochemistry, University of Missouri, Columbia, MO, 65211, USA.\', \'Department of Veterinary Pathobiology, College of Veterinary Medicine, University of Missouri, Columbia, MO, 65211, USA.\', \'Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, NE, 68131, USA; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden. Electronic address: sid.byrareddy@unmc.edu.\', \'Bond Life Sciences Center, University of Missouri, Columbia, MO, 65211, USA; Department of Veterinary Pathobiology, College of Veterinary Medicine, University of Missouri, Columbia, MO, 65211, USA; Division of Clinical Microbiology, Department of Laboratory Medicine, Karolinska Institute, Stockholm, Sweden; Sanctum Therapeutics Corporation, Sunnyvale, CA, USA. Electronic address: singhka@missouri.edu.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}